MedTrace Logo

Integrative Molecular Analysis of Individual Radiosensitivity in Pediatric Oncology

NCT06033183 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-11-22

No results posted yet for this study

Summary

Analysis of the individual radiosensitivity in pediatric oncology

Conditions

  • Radiosensitivity
  • Pediatric Cancer
  • Radiation Toxicity

Interventions

BIOLOGICAL

Blood sample

Blood sample collection : 2 X 5 ml

Sponsors & Collaborators

  • Centre Francois Baclesse

    collaborator OTHER

  • Centre Hospitalier Universitaire de Caen

    collaborator OTHER

  • Institut de cancérologie Strasbourg Europe

    collaborator UNKNOWN

  • Centre Oscar Lambret, Lille, France

    collaborator UNKNOWN

  • Neolys

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
3 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-02
Primary Completion
2027-08-30
Completion
2027-10-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06033183 on ClinicalTrials.gov